跳到正文
Naoto T Ueno, MD, PhD· @teamoncology · X·· 2026-04-18评分60
正文

暂无中文译文,显示英文原文。

Will China only data be acceptable for FDA? That is a concern per Dr Pazdur. “We need multiregional trial.” #AACR26

热度 2 · 1 赞 · 1 回复 · 0 转发

来源:Naoto T Ueno, MD, PhD · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org